{"id":801639,"date":"2023-06-26T05:40:37","date_gmt":"2023-06-26T07:40:37","guid":{"rendered":"https:\/\/teknomers.com\/fr\/action-de-sanofi-dans-le-rouge-succes-de-letude-sanofi-sur-les-dossiers-des-medicaments-contre-lhemophilie\/"},"modified":"2023-06-26T05:40:44","modified_gmt":"2023-06-26T07:40:44","slug":"action-de-sanofi-dans-le-rouge-succes-de-letude-sanofi-sur-les-dossiers-des-medicaments-contre-lhemophilie","status":"publish","type":"post","link":"https:\/\/teknomers.com\/fr\/action-de-sanofi-dans-le-rouge-succes-de-letude-sanofi-sur-les-dossiers-des-medicaments-contre-lhemophilie\/","title":{"rendered":"Action de Sanofi dans le rouge : succ\u00e8s de l&#8217;\u00e9tude Sanofi sur les dossiers des m\u00e9dicaments contre l&#8217;h\u00e9mophilie"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<p>Sanofi a remport\u00e9 un essai r\u00e9ussi avec son m\u00e9dicament contre l&#8217;h\u00e9mophilie Altuviiio.<\/p>\n<div>\n<p>Comme l&#8217;a annonc\u00e9 la soci\u00e9t\u00e9 pharmaceutique fran\u00e7aise Sanofi, les donn\u00e9es r\u00e9cemment publi\u00e9es d&#8217;une \u00e9tude de phase 3 ont confirm\u00e9 l&#8217;efficacit\u00e9 et l&#8217;innocuit\u00e9 du m\u00e9dicament. <\/p>\n<p>  Le m\u00e9dicament prophylactique, qui a \u00e9t\u00e9 approuv\u00e9 par la Food and Drug Administration des \u00c9tats-Unis en f\u00e9vrier, ne n\u00e9cessite qu&#8217;une seule dose pour pr\u00e9venir les saignements. <!-- sh_cad_2 --><\/p>\n<p>Dans les \u00e9changes sur EURONEXT, l&#8217;action Sanofi a temporairement perdu 0,67% \u00e0 97,94 euros.\n<\/p>\n<p>  DJG\/DJN\/mgo\/cbr <\/p>\n<p>  PARIS (Dow Jones)<\/p>\n<\/div>\n<div id=\"\">\n<h2 class=\"headline headline--h4\">Produits \u00e0 effet de levier s\u00e9lectionn\u00e9s sur Sanofi SA<\/h2>\n<p>Avec les knock-outs, les investisseurs sp\u00e9culatifs peuvent participer de mani\u00e8re disproportionn\u00e9e aux mouvements de prix.  S\u00e9lectionnez simplement l&#8217;effet de levier souhait\u00e9 et nous vous montrerons les produits ouverts adapt\u00e9s sur Sanofi SA<\/p>\n<p class=\"font-color-red display-none\" id=\"lvgCustomHandleInfo\">L&#8217;effet de levier doit \u00eatre compris entre 2 et 20<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.finanzen.net\/nachricht\/aktien\/prophylaxe-medikament-sanofi-aktie-im-minus-sanofis-haemophilie-medikament-verzeichnet-studienerfolg-12580823\" rel=\"nofollow noopener\" target=\"_blank\">ttn-fr-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sanofi a remport\u00e9 un essai r\u00e9ussi avec son m\u00e9dicament contre l&#8217;h\u00e9mophilie Altuviiio. Comme l&#8217;a annonc\u00e9 la soci\u00e9t\u00e9 pharmaceutique fran\u00e7aise Sanofi, les donn\u00e9es r\u00e9cemment publi\u00e9es d&#8217;une \u00e9tude de phase 3 ont confirm\u00e9 l&#8217;efficacit\u00e9 et l&#8217;innocuit\u00e9 du m\u00e9dicament. Le m\u00e9dicament prophylactique, qui a \u00e9t\u00e9 approuv\u00e9 par la Food and Drug Administration des \u00c9tats-Unis en f\u00e9vrier, ne n\u00e9cessite [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":801640,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[1063,841,429,133,8105,65,42148,170651,2984,4729,77674,1864,60],"class_list":["post-801639","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-action","tag-contre","tag-dans","tag-des","tag-dossiers","tag-les","tag-letude","tag-lhemophilie","tag-medicaments","tag-rouge","tag-sanofi","tag-succes","tag-sur"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/801639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/comments?post=801639"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/801639\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media\/801640"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media?parent=801639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/categories?post=801639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/tags?post=801639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}